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Epidemiologic and clinical studies have 
linked elevated concentrations of ambient 
particulate matter (PM) to adverse health 
effects throughout the industrialized world 
(Kleeberger 2005). In urban environments, 
combustion-derived nanoparticles (CDNPs) 
such as soot particles dominate PM num-
ber concentrations and contribute signifi-
cantly to the total PM surface area. Typically, 
these particles consist of a carbon core coated 
with potentially toxic air pollutants consist-
ing of hundreds of organic chemicals and 
many transition metals (Kreyling et al. 2004; 
Oberdörster et al. 2005). At present, it is 
commonly hypothesized that the toxicity of 
ultrafine soot particles is largely driven by 
adsorbed redox-active components [e.g., poly-
aromatic hydro  carbons (PAHs)], which par-
ticipate in redox-cycling reactions generating 
reactive oxygen species (ROS). These ROS 
can cause oxidative stress responses that may 
result in pulmonary or even systemic inflam-
mation (Li et al. 2003a; Risom et al. 2005). 
Ultimately, these processes may promote the 
progression of atherosclerosis and precipi-
tate acute cardiovascular responses ranging 
from increased blood pressure to myocardial 
infarction (Delfino et al. 2005). To coun-
teract the adverse effects of oxidative stress 
generated by redox cycling and electrophilic 
compounds, nature “developed” an elaborate 
defense system to maintain redox homeo-
stasis. This system includes a series of anti-
oxidant enzymes, in particular, the so-called 
phase II xenobiotic metabolism enzymes that 
metabolize redox-cycling chemi  cals, eliminate 
excessive ROS, and protect cells against the 
damaging effects of electrophiles and oxidants 
(Winyard et al. 2005). A disturbance of the 
cellular redox equilibrium and related dis-
proportionate oxidative stress is well known 
to trigger multiple stress kinase pathways and 
redox-sensitive transcription factors, such as 
nuclear factor-erythroid 2-p45–related fac-
tor 2 (Nrf2), which activates the expression 
of anti  oxidant and cytoprotective genes, as 
well as the nuclear localization of nuclear fac-
tor kappa B (NF-kB) and activator protein-1 
(AP-1), which play key roles in gene promo-
tion for inflammatory mediators (Cho et al. 
2006; Rahman et al. 2006).
Identification of the particle proper-
ties that are most relevant for promoting 
adverse health effects is crucial not only for 
our mechanistic understanding but also for 
the implementation of strategies for improv-
ing air quality. For different kinds of par-
ticles with low toxicity and solubility, particle 
surface area has shown to be a useful dose 
metric for the characterization of particle-
induced neutrophil response in the exposed 
lung (Oberdörster et al. 2005). Inflammatory 
effects of diesel exhaust particles (DEP) appear 
to be driven by particle surface area (Heinrich 
et al. 1995), although the type of organic 
(Baeza-Squiban et al. 1999) and metal (Ball 
et al. 2000) components also appear to play a 
role in oxidative and proinflammatory effects 
and subsequent pathogenicity. This is consis-
tent with studies describing different classes of 
surface toxicity pointing to different pathways 
of particle-related stress induction (Dick et al. 
2003; Donaldson et al. 2005; Duffin et al. 
2002; Warheit et al. 2006).
In a previous study, we found that for 
six different types of CDNPs, the organic 
carbon content (OC) had a much weaker 
impact on the acute inflammatory response 
in the lungs of mice (24 hr after intratracheal 
instillation) than did Brunauer, Emmett, and 
Teller (BET) surface area, with predictive 
values of 0.0286 versus < 0.0001, respec-
tively (Stoeger et al. 2006). Although BET 
surface area appears to be the single most 
relevant parameter for the prediction of par-
ticle toxicity, it is likely that other parameters 
such as the presence of free radicals, particle 
charge, and the bioavailability of adsorbed 
components may explain the observed differ-
ences in surface toxicity (Stoeger et al. 2006; 
Wittmaack 2007).
The objective of the present study was 
to assess the possibility of predicting particle 
toxicity based on the combined information 
from a cell-free in vitro test for the innate oxi-
dative potency (OxPot) of particles and a gene 
expression analysis targeting inflammation, 
stress, and detoxification-related genes. Here 
we relate the results from both tests to our 
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Ba c k g r o u n d: The inhalation of combustion-derived nanoparticles (CDNPs) is believed to cause 
an oxidative stress response, which in turn may lead to pulmonary or even systemic inflammation.
oB j e c t i v e a n d Me t h o d s : In this study we assessed whether the in vivo inflammatory response—
which is generally referred to as particle toxicity—of mice to CDNPs can be predicted in vitro by 
a cell-free ascorbate test for the surface reactivity or, more precisely, oxidative potency (OxPot) of 
particles.
re s u l t s: For six types of CDNPs with widely varying particle diameter (10–50 nm), organic con-
tent (OC; 1–20%), and specific Brunauer, Emmett, and Teller (BET) surface area (43–800 m2/g), 
OxPot correlated strongly with the in vivo inflammatory response (pulmonary polymorphonuclear 
neutrophil influx 24 hr after intratracheal particle instillation). However, for CDNPs with high 
organic content, OxPot could not explain the observed inflammatory response, possibly due to 
shielding of the OxPot of the carbon core of CDNPs by an organic coating. On the other hand, 
a pathway-specific gene expression screen indicated that, for particles rich in polycyclic aromatic 
hydrocarbon (PAHs), cytochrome P450 1A1 (CYP1A1) enzyme-mediated biotransformation of bio-
available organics may generate oxidative stress and thus enhance the in vivo inflammatory response.
co n c l u s i o n: The compensatory nature of both effects (shielding of carbon core and biotransfor-
mation of PAHs) results in a good correlation between inflammatory response and BET surface 
area for all CDNPs. Hence, the in vivo inflammatory response can either be predicted by BET sur-
face area or by a simple quantitative model, based on in vitro OxPot and Cyp1a1 induction.
key w o r d s : air pollution, BET, biotransformation, carbonaceous particles, Cyp1a1, dose response, 
nanoparticles, nanotoxicity, organic compounds, oxidative stress, particle toxicity, soot par-
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previously published in vivo data on the acute 
inflammatory response of mice for six types of 
CDNPs (Stoeger et al. 2006) and introduce a 
simple two-parameter model to quantitatively 
describe the toxicity of CDNPs from the 
OxPot and bioavailability of organic compo-
nents. Ultimately, this model may serve as an 
additional step toward introducing a cell-free 
test for nanotoxicology that is reliable enough 
to make animal studies obsolete.
Materials and Methods
Particles. In the present study we used the 
same six CDNP types as we described previ-
ously (Stoeger et al. 2006). Briefly, we pur-
chased DEPs [standard reference material 
SRM-1650a; National Institute of Standards 
and Technology (NIST), Gaithersburg, MD, 
USA] and PrintexG (PtxG) and Printex90 
(Ptx90; pigment black; Degussa, Frankfurt, 
Germany) and generated and filter-sampled 
SootH (high OC), SootL (low OC), and ultra-
fine carbon particles (UfCPs) in our labora-
tory. We produced SootH and SootL particles 
by a well-controlled diffusion flame (CAST 
burner, Matter Engineering AG, Wohlen, 
Switzerland) with low and high oxygen-to-
fuel ratios, respectively, resulting in soot par-
ticles with different amounts (and types) of 
organic compounds (Matuschek et al. 2007). 
The UfCPs, generated by spark discharge 
from graphite electrodes (GFG1000, Palas, 
Karlsruhe, Germany) (Roth et al. 2004), are 
noncombustion-derived particles with low 
OC, large specific surface area, and structural 
and compositional similarities with modern 
(Euro IV) diesel soot (Su et al. 2004). Table 1 
lists the BET surface area [determined using 
the method described by Brunauer, Emmett, 
and Teller (1938)] and OC of all six particle 
types as reported previously (Stoeger et al. 
2006) covering a wide range from about 40 
to 800 m2/g and from 1% to 20% OC. The 
(primary) particle diameter of the nanoparticle 
types ranged from about 10 to 50 nm (Stoeger 
et al. 2006). For the biological analysis of the 
CDNPs described below, we used the entire 
particles rather than solvent extracts.
Determination of the OxPot of the particles. 
In living organisms, vitamin C (l-ascorbate), a 
highly effective antioxidant, is consumed as 
it protects the body against oxidative stress. 
Therefore, we used the depletion of ascorbate 
in an aqueous particle suspension as a cell-free 
in vitro test for the OxPot of particles, where 
the absence of any metabolic activity in a cell-
free system guarantees that this test charac-
terizes the particles’ innate (in absence of 
metabolic activation) OxPot presumably related 
to the surface reactivity of the particles.
For each particle type, we incubated ali-
quots of 5, 1, and 0.2 µg for 40 min in an 
aqueous ascorbate solution (100 µL of 100 µM 
ascorbate in phosphate-buffered saline; this 
corresponds to 2.5 nmol ascorbate per 25 µL). 
After removal of the particles by centrifuga-
tion (30,000g/15 min/4°C), we quantified the 
antioxidative capacity of 25 µL of supernatant 
using the photochemiluminescence (PCL) 
method (Photochem, Analytik Jena AG, Jena, 
Germany), in which the fast photochemical 
excitation of radical formation is combined 
with sensitive luminometric detection (Popov 
and Lewin 1999). We performed two mea-
surements for each particle type and concen-
tration (Figure 1) and determined the particles’ 
innate OxPot, expressed as consumed ascorbate 
(nanomoles) per particle mass (micrograms) 
from the slope (not the ratio) of the measured 
ascorbate consumption and particle mass in 
order to avoid biases due to potential zero off-
sets. For UfCP and SootL particles, the high-
est dose of 5 µg had to be discarded because a 
consumption of 2.4 nmol of 2.5 nmol ascor-
bate points to saturation issues.
Determination of the inflammatory effi­
cacy of the particles. In the present study, we 
used the in vivo animal exposure data from 
our previous study (Stoeger et al. 2006). In 
brief, for each particle type, we determined the 
response of eight female BALB/cJ mice (21.1 ± 
1 g) after intratracheal instillation of 5, 20, or 
50 µg CDNPs in 50 µL aqueous suspension or 
pure water (sham control), except for UfCP, 
which also included instillations with 0.5 and 
2 µg particles. We treated animals humanely 
and with regard for alleviation of suffering; 
experimental protocols were reviewed and 
approved by the Bavarian Animal Research 
Authority (approval no. 211-2531-108/99). At 
24 hr after instillation, we performed broncho-
alveolar lavage (BAL) and assessed BAL fluid 
for polymorphonuclear neutrophils (PMNs) 
as a measure of the inflammatory cellular 
response. In the present study, the previously 
reported absolute numbers of PMNs (Stoeger 
et al. 2006) were normalized by the number 
of BAL leukocytes [Supplemental Material, 
Figure 1 (http://www.ehponline.org/mem-
bers/2008/11370/suppl.pdf)], thus eliminat-
ing some bias due to varying effectiveness of 
cell retrieval by the lavage procedure (especially 
for 50 µg PtxG).
Using these data, in the present study we 
defined the (in vivo) inflammatory efficacy 
(IEf) as the 20% PMN effect level divided 
by the particle mass causing this effect 
level (M20%PMN), that is, IEf = 20% PMN/
M20%PMN (%PMN/µg). We chose the 20% 
PMN threshold because it is significantly 
different from the sham response (~ 2%), it 
is clearly beneath saturation levels (> 40%), 
and it is exceeded by all six particle types 
[See Supplemental Material, Figure 1 (http://
www.ehponline.org/members/2008/11370/
suppl.pdf)]. We derived the M20%PMN values 
by interpolation between the two PMN data 
points bracketing the 20% effect level.
Quantification of gene and protein expres­
sion. For expression analysis, lavaged lungs 
from the 20 µg exposure were homogenized 
using the FastPrep FP120 Cell Disruptor 
(BIO101/Savant Instruments Inc., Holbrook, 
NY, USA) automat with Lysing Matrix Tube 
D (MP Biomedicals, Illkirch, France) and 
subjected to either RNA or protein extrac-
tion (four mice per group). RNA isolation 
from lung homogenates was processed using 
the RNeasy Kit (Qiagen, Hilden, Germany). 
For quantitative reverse-transcriptase 
  polymerase chain reaction (PCR), we used 
Figure 1. Cell-free oxidative effect (mean ± SE) of 
the six types of CDNP displayed as the amount of 
ascorbate consumed by the respective particle 
mass (5, 1, and 0.2 µg). 
*Values that were negatively biased because of their 
proximity to the saturation level (2.5 nmol) were discarded 
for the calculation of OxPot (Table 1).
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Table 1. Physicochemical and biological particle properties.
  BET surface area  Percent OC
Particle  (m2/g)   (NIOSH 5040)a  IEf (% PMN/µg)   OxPot (nmol/µg)b   R2c 
UfCP  800  17 (< 5)d   4.8  0.839  1.00e 
SootL  441  7  2.5  0.617  1.00e 
SootH  268  19  1.7  0.057  0.99
Ptx90  272  2  1.2  0.278  1.00
DEP  108  20f   0.5  0.026  0.27g 
PtxG  43  1  0.4  0.024  0.88
aThe organic carbon fraction was determined with a thermooptical method according to the National Institute for 
Occupational Safety and Health (NIOSH) 5040 standard protocol (Cassinelli and O’Connor 1998). bOxPot from the slope of the 
consumed ascorbate versus particle mass (see Figure 1). cR2 gives the significance (goodness of fit) of the linear regres-
sion. dThe NIOSH 5040 value of 17% (Stoeger et al. 2006) is unrealistically high for spark-generated (pure) carbon particles; 
more detailed chemical analysis suggests that UfCPs contained < 5% of organic matter (Frampton et al. 2004; Matuschek 
et al. 2007). eHere R2 = 1 because only two data points were available for UfCP and SootL because of saturation issues (see 
Figure 1). fThis value was not obtained according to the NIOSH protocol; it refers to the solvent (Soxhlet)-extractable mass 
fraction as reported by NIST (2000). gThe low R2 value is at least in part due to the small effect level for DEP.Stoeger et al.
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1 µg total DNase I–treated RNA for the 
first-strand cDNA reaction using hexamer 
primer (Promega, Mannheim, Germany) and 
Superscript II reverse transcriptase (Invitrogen, 
Karlsruhe, Germany). We pooled cDNA sam-
ples from each experimental group and quan-
tified transcript levels using Absolute QPCR 
SYBR Green Mix plus ROX kit (ABgene, 
Hamburg, Germany) with the ABI Prism 
7000 Sequence Detection System (Applied 
Biosystems, Foster City, CA, USA). We used 
the comparative CT (threshold cycle) method 
to calculate the relative abundance of tran-
script (Applied Biosystems 1997). For nor-
malization, we used 18S RNA [GenBank 
accession no. NT_039649.7 (National Center 
for Biotechnology Information 2008)] as the 
reference gene to derive the fold increase in 
relation to the sham control group. Details 
of the primer and sequence specifications 
are given in Supplemental Material, Table 1 
(http://www.ehponline.org/  members/ 
2008/11370/suppl.pdf).
We performed extraction of cytoplasmic 
lung protein in RIPA buffer plus Protease 
Inhibitor Cocktail III (Merck Chemicals, 
Darmstadt, Germany). We pooled 20 µg 
of total lung protein from each of the eight 
experimental groups (six CDNP types and two 
controls) and separated it by sodium dodecyl 
sulfate gel electrophoresis using the XCell II 
Blot Module and NuPage Novex Bis-Tris Gels 
and blotted to polyvinyl difluoride membranes 
(Invitrogen). The following primary anti-
bodies were used: rabbit anti-cyclo  oxygenase-2 
(COX2; ab15191; Abcam, Cambridge, UK), 
rabbit anti-cytochrome P450 1A1 (CYP1A1; 
sc-20772; Santa Cruz Biotechnology, 
Heidelberg, Germany), rabbit anti-rat liver 
glutathione S-transferase α1 (GST-Ya; AB 
0009; Gentaur, Aachen, Germany), rabbit 
anti-heme oxygenase-1 (HO1; SPA 895; 
Biomol, Hamburg, Germany), rabbit anti-heat 
shock 70-kDa protein 1B (HSP70; SPA 812, 
Biomol), goat anti-NAD(P)H dehydrogenase 
[quinone] 1 (NQO1; IMG-3033, Biomol), 
and, as loading control, mouse mono  clonal 
anti–β-actin (ACTB), AC-15 (A1978; 
Sigma-Aldrich, Taufkirchen, Germany). 
We applied horseradish peroxidase–linked 
species-specific secondary antibody for pri-
mary antibody detection, donkey anti-
rabbit IgG (Amersham/GE Healthcare, 
Buckinghamshire, UK), rabbit anti-goat 
(Chemicon International, Millipore Corp., 
Billerica, MA, USA), and sheep anti-mouse 
(Amersham/GE Healthcare), using the ECT 
Plus Detection System (Amersham/GE 
Healthcare). Scanned blots were analyzed 
using the Syngene software image analysis 
program (Syngene, Cambridge, UK) with 
baseline correction setting “rolling disc.” 
Protein expression derived from quantified 
densities of respective bands were normalized 
to ACTB and expressed as fold change rela-
tive to sham controls.
Statistical analyses. All values are reported 
as the mean ± SE. We used analysis of variance 
calculated by Statgraphics software (STSC 
Inc., Rockville, MD, USA) to establish the sta-
tistical significance of differences between the 
experimental groups. We applied the Tukey 
honestly significant difference procedure to 
evaluate the significant differences between 
the exposed animals and the sham control 
group. We considered differences significant 
at p < 0.05.
Results
In vitro OxPot, in vivo IEf, and surface area 
of the particles. As indicated in our previous 
study (Stoeger et al. 2006), Figure 2A con-
firms the excellent linear correlation between 
inflammatory response and BET surface area 
for the six types of CDNPs used in the pres-
ent study. For a wide dynamic range of more 
than a factor of 10 (with UfCP and PtxG 
at the upper and lower end, respectively), 
the differences in BET surface area explain 
98% (R2) of the observed variability in IEf. 
Neglecting the small intercept of 0.055% 
PMN/µg, the slope of 0.006% PMN/mm2 
indicates that, on average, a particle surface 
area of 33 cm2 is required to induce a 20% 
influx of PMNs into the lungs. Figure 2B 
shows a reduced but still strong linear cor-
relation between the IEf and OxPot of the 
particles (R2 = 0.77; IEf = 5.14OxPot; forced 
through the origin) with an identical order of 
descending IEf and OxPot except for SootH, 
which has a more than three times higher 
IEf than expected from its OxPot. This can 
be interpreted as a reduced surface-specific 
OxPot, as illustrated in Figure 2C, which 
clearly shows SootH (and, to a lesser degree, 
DEP) below the trend line based on the other 
four data points.
Gene expression analysis reveals bio­
activation of particle­borne organics. To 
identify the reason for the irregular behavior 
of SootH, in the lungs of mice 24 hr after the 
instillation of 20 µg of SootH, we analyzed 
the expression patterns of 50 genes represent-
ing different biologic response types, includ-
ing inflammation, stress response, metal 
detoxification, and phase I and II detoxifica-
tion of xenobiotics such as PAHs.
Table 2 displays the expression of the 
22 most notably regulated genes [see also 
Supplemental Material, Figure 2 (http://
www.ehponline.org/members/2008/11370/
suppl.pdf)] in terms of fold induction in rela-
tion to sham controls; that is, unity represents 
the absence of gene regulation. We averaged 
the abundances of pro  inflammatory marker 
genes (rows 2 through 9) in Table 2 for each 
particle type to obtain a mean score for a 
transcriptional proinflammatory response— 
“proinflammatory synopsis.” Ranking the 
particles in terms of the proinflammatory 
synopsis (Table 2) and PMN-based cellular 
lung inflammation (IEf in Table 1) shows 
good agreement and validates the relevance of 
our RNA expression data.
We gained insight into transcriptional 
regulations related to general stress response 
by examining the inducible 70-kDa heat 
shock gene Hsp1a1 as well as the metallothio-
nein 1 and 2 genes (Mt1 and Mt2), all known 
to be up-regulated directly by oxidative stress 
and toxic chemicals—particularly heavy met-
als. Only PtxG particles showed a more than 
2-fold increase in Hsp1a1 lung transcript lev-
els 24 hr after instillation; for the other car-
bon black sample (Ptx90), mRNA levels were 
3-fold decreased. Gene expression of Mt1 
and Mt2 was increased for UfCP only; for 
DEP, these genes were 2-fold repressed. This 
indicates that, although the toxicity of metals 
may have contributed to the oxidative stress 
Figure 2. Relationships between the in vitro OxPot, in vivo IEf, and BET surface area of the six types of CDNPs. (A) BET surface area versus IEf with the linear 
regression line. (B) OxPot versus IEf (the linear regression line was forced through the origin). (C) BET surface area versus oxidative potency (the linear regression 
was based on all data points except SootH and DEP). 
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induced by UfCP and DEP, metals do not 
explain the extreme deviation of SootH from 
the linear response curve or the general trend 
in Figure 2B.
The expression analysis of 11 selected 
detoxification enzymes (Cyp1a1, Cyp1b1, 
Aldh3a1, Gclc, Gpx1, Gpx4, Gsr, Gsta1, 
Hmox1, Nqo1, and Ogg1) revealed that each 
particle type induced at least one of these 
genes. However, the only gene whose expres-
sion was induced specifically by SootH (3.9-
fold up-regulated) and, to a lower extent, by 
DEP (1.6-fold up-regulated) was the phase I 
xenobiotic metabolizing enzyme Cyp1a1. To 
validate these data derived from pooled sam-
ples, we also quantified Cyp1a1 expression 
in SootH-instilled mice on the single-animal 
level (n = 4). Single-animal analysis con-
firmed our previous data detecting an induc-
tion of 4.0 ± 0.4 that is significantly (p = 
0.001) different from sham controls [see 
Supplemental Material, Figure 2 (http://
www.ehponline.org/members/2008/11370/
suppl.pdf)]. Furthermore, low-OC particles 
(OC < 7%) were either not significantly 
affected (Ptx90, PtxG) or down-regulated 
(SootL, UfCP). In contrast to Cyp1a1, the 
closely related cytochrome 450 phase I 
enzyme isoform Cyp1b1 did not show regula-
tion by more than 2-fold. The investigated 
phase II enzymes Gclc, Gpx1, Gpx4, and Gsr 
were more than 2-fold induced by UfCP, but 
none of them was more than 2-fold induced 
by the OC-rich DEP and SootH particles. 
8-Oxoguanine DNA glycosylase (Ogg1), 
a DNA repair enzyme whose expression is 
associated with organics-related DNA adduct 
formation (Sorensen et al. 2003), is more 
than 2-fold induced by Ptx90 and UfCP and 
thus also is not a suitable marker for OC-rich 
  particle instillation.
In summary, our expression data iden-
tify Cyp1a1 as the only marker gene whose 
expression is specifically induced by OC-rich 
particle exposure.
OC­rich soot particles induce expression 
of CYP1A1 protein in the lung. Because the 
functional relevance of induced gene expres-
sion needs to be confirmed by a subsequent 
increase in expressed protein levels, we ana-
lyzed six of the investigated marker genes 
(Hmox1, Ptgs2, Cyp1a1, Gsta1, Hsp1a1, and 
Nqo1) on the protein level (HO1, COX2, 
CYP1A1, GSTYa1, HSP70, and NQO1) 
by immunoblotting of cytoplasmic extracts 
from lungs 24 hr after particle instillation 
(Figure 3). As expected from our mRNA 
data, only the expression of CYP1A1 pro-
tein was strongly induced by instillation of 
OC-rich SootH particles. Moreover, particle 
exposure did not influence the abundance 
of any of the other investigated proteins. 
Quantification of protein expressions relative 
to sham control and normalized to ACTB 
revealed a 21-fold induction of CYP1A1 pro-
tein expression for SootH particles and a 1.6- 
and 1.4-fold induction for DEP and PtxG, 
respectively. UfCP and Ptx90 particle instil-
lation suppressed expression of the CYP1A1 
protein to 40% and 30% of control levels, 
respectively. CYP1B1 was not detectable at 
all (not shown in Figure 3), and the phase II 
enzymes NQO1, GSTYa1, and HO1 did not 
indicate specific responses at the 24-hr time 
point. The inflammatory mediator COX2 
(Ptgs2) was suppressed up to 2-fold 24 hr 
after instillation of all particles.
Immunohistologic localization of CYP1A 
expression. Immunohistologic detection of 
CYP1A1 protein expression in lungs 24 hr 
after instillation of 20 µg particles revealed 
the strongest expression for SootH-exposed 
lungs (Figure 4) and somewhat weaker signals 
for DEP-exposed lungs (data not shown). We 
identified CYP1A1-positive cells to be mainly 
alveolar epithelial cells, but we also identi-
fied some positive alveolar macrophages. No 
clear signal could be detected in lungs from 
untreated and sham-exposed mice or after 
UfCP, Printex, or SootL instillation.
Discussion
OxPot is a strong indicator for particle­
induced inflammatory effects. Several studies 
indicate that the OxPot of the particle surface 
is critical for biologic responses related to 
Table 2. Gene expression analysis (fold change relative to sham control) showing the mean transcript 
abundance assessed by quantitative PCR in the lungs of mice 24 hr after instillation of six types of CDNPs 
(20 µg).
Pathway  Gene  DEP  PtxG  Ptx90  SootH  SootL  UfCP
Proinflammatory  Csf2  2.0  2.0  5.2  5.7  6.5  3.4
  Cxcl1  0.7  1.9  4.0  5.6  7.5  15.9
  Cxcl5  0.4  2.5  2.4  4.9  4.4  9.6
  Il6  1.0  1.5  1.7  3.0  5.5  5.6
  Il1b  0.9  1.1  1.7  1.8  1.8  1.0
  Mmp9  0.8  1.6  1.9  2.4  1.7  2.6
  Ptgs2  1.1  2.1  1.4  1.4  1.3  1.1
  Tnfa  1.3  0.9  1.6  1.8  2.1  0.9
  Proinflammatory synopsis    1.0  1.7  2.5  3.3  3.9  5.0
Stress response  Hspa1a  0.6  2.6  0.3  0.7  1.0  1.5
  Mt1  0.5  1.6  0.9  1.4  1.1  4.4
  Mt2  0.4  0.8  1.1  1.1  1.3  3.6
Detoxification, phase I  Cyp1a1  1.6  1.2  0.9  3.9  0.4  0.4
  Cyp1b1  0.6  0.7  0.8  1.4  1.3  0.7
Detoxification, phase II  Aldh3a1  0.4  0.5  0.6  1.0  0.6  0.5
  Gclc  0.8  2.4  1.5  1.5  1.9  4.3
  Gpx1  0.9  1.4  1.2  1.3  1.3  3.1
  Gpx4  0.6  0.8  0.9  0.8  0.8  3.1
  Gsr  0.7  2.1  1.3  1.2  1.3  2.5
  Gsta1  0.5  0.5  0.6  1.0  0.7  0.5
  Hmox1  1.1  1.8  1.6  1.9  1.9  0.9
  Nqo1  1.1  2.2  2.0  1.9  1.7  0.9
  Ogg1  1.3  1.9  2.8  1.9  1.5  2.5
We examined 50 genes related to various cellular response pathways, with the 22 most notably changed included here. 
Averaging expression levels for the eight genes indicative for the inflammatory pathway (proinflammatory synopsis) pro-
vides a proxy for the severity of inflammation. 
Figure 3. Protein expression and quantification of selected markers. (A) Protein expression analyzed by 
immunoblotting. (B) For quantification, signal densities were normalized to ACTB loading control and are 
displayed relative to the respective expressions in sham controls. CYP1A1 was the only marker that was 
induced for the known high-OC particles SootH (21-fold) and DEP (1.6-fold). It even was mildly induced for 
PtxG (1.4-fold). 
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inflammation (Beck-Speier et al. 2005; Li 
et al. 2003b; Xia et al. 2006). Because for 
the six types of CDNPs investigated here the 
OxPot (based on a cell-free assay) can explain 
only about 80% of the observed variability 
in IEf (R2 = 0.77; Figure 2B), at least one 
more parameter contributes to the observed 
in vivo particle toxicity (IEf). Furthermore, 
particles with high OC (DEP, SootH) dis-
play a mitigated surface-specific OxPot com-
pared with low-OC particles (Figure 2C). 
This could indicate that an organic coating 
shields the active structures at the surface of 
the carbon matrix and thus prevents radi-
cal formation. On the other hand, if OxPot 
were the only pathway of inflammation, the 
surface-specific IEf of DEP and SootH should 
be reduced compared with low-OC parti-
cles (e.g., SootL, UfCP). Because Figure 2A 
does not show this (DEP and SootH do not 
lie significantly below the linear regression 
curve), the mitigating effect of the organic 
coating on OxPot is compensated by another 
mechanism, which only occurs in the in vivo 
and not in the in vitro test.
Biotransformation of particle­adsorbed 
organics contributes to inflammatory effects. 
The prime candidates for this additional 
mechanism are the enzymatic biotransfor-
mation of initially nontoxic (nonoxidizing) 
organic compounds into toxic derivatives and, 
to a lesser degree, the nonenzymatic, catalyst-
mediated formation of free radicals such as 
hydroxyl radicals via Fenton chemis  try by, for 
example, transition metals. The latter would 
not necessarily require a metabolic active cell, 
and the corresponding OxPot would prob-
ably be detected by our ascorbate-PCL–based 
OxPot measurement. However, the fact that 
metal-inducible Mt1 and Mt2 genes (Adams 
et al. 2002) were not up-  regulated by DEP 
and SootH (Table 2) suggests no metal 
involvement.
On the other hand, the induced expres-
sion of both the Cyp1a1 gene and CYP1A1 
protein for SootH (3.9- and 21-fold for gene 
and protein, respectively) and, to a much 
lesser degree, for DEP (1.6-fold for both gene 
and protein) indicates that metabolic detoxi-
fication of organics takes place for particles 
with high OC. In addition, PtxG, the particle 
type with the lowest OC (1%), also shows a 
small induction (1.2- and 1.4-fold for gene 
and protein, respectively). All other low-OC 
particles show a down-regulation in both the 
Cyp1a1 gene and CYP1A1 protein. Hence, it 
is obviously not only the amount of organics, 
but also the type of organics, that determines 
the regulation of Cyp1a1.
Pulmonary expression of Cyp1a1 has 
previously been identified as a possible bio-
marker of exposure to DEPs in vitro and 
in vivo (Bonvallot et al. 2001; Takano et al. 
2002). For instance, Takano et al. (2002) 
instilled DEP from a light-duty automobile 
source and observed Cyp1a1 transcript levels 
to be about 5-fold induced 24 hr after instil-
lation of 50 µg DEP per mouse, whereas no 
effect was detected for 10 µg. (Bonvallot et al. 
2001, Takano et al. 2002). This is consistent 
with results from our present study, in which 
instillation of 20 µg DEP from a heavy-duty 
diesel engine (SRM 1650a) mildly induced 
the Cyp1a1 expression on RNA and protein 
level (1.6-fold). 
Two main families of organic compounds 
that are known to be adsorbed onto ambi-
ent CDNPs are PAHs and quinones (Health 
Effects Institute 2002). After cellular uptake, 
PAHs could be desorbed from the CDNPs, 
become bioavailable to bind to the cytoso-
lic aryl hydrocarbon receptor (AHR) and 
thereby induce target gene expression such 
as that of phase I metabolizing cytochrome 
P450 enzymes. The toxicity of many PAHs 
is known to depend on their bioactivation 
by P450 enzymes (Ramadoss et al. 2005). 
The hypothesis of PAH-related bioactivation 
of toxic compounds for SootH and DEP (as 
well as for PtxG) is supported by the chemical 
analysis of the particles. Both liquid chroma-
tography and thermo  analytical investigation 
have revealed significant amounts of PAHs 
for SootH (~ 1%), exceeding those from 
SootL by a factor of about 50 (Schroeppel 
et al. 2003). Moreover, detailed chemical spe-
ciation reveals the presence of aromatic com-
pounds such as benz(a)anthracene, benzo(k)
fluoranthene, and/or benzo(a)pyrene, in sig-
nificant amounts only on SootH, DEP, and 
PtxG samples (Matuschek et al. 2007; NIST 
2000), which have been described as potent 
inducers of Cyp1a1 (Till et al. 1999). 
Mechanistic considerations. PAH metabo-
lism by Cyp1a1 produces reactive electrophilic 
metabolites, including ROS (Baulig et al. 
2003; Martignoni et al. 2006). In the present 
study, we did not directly quantify ROS for-
mation in the lungs of instilled mice, but we 
quantified several proinflammatory genes that 
are known to be regulated by redox-sensitive 
transcription factors such as NF-kB and AP-1 
(Cho et al. 2006; Rahman et al. 2006). In vivo 
we found the lung transcripts for the cytok-
ines Csf2, Cxcl1, Cxcl5, and Il6—all known 
to be largely regulated by NF-kB and AP-1 
(reviewed by Castranova 2004)—to be induced 
by SootH and SootL instillation at a similar 
level (Table 2), whereas the in vitro OxPot of 
SootL exceeded that of SootH by a factor of 
about 6 (Figure 2B). Again, this suggests that 
two different mechanisms are responsible for 
the toxicity of SootL and SootH particles, one 
related to the particles’ innate OxPot and the 
other possibly to bioactivation of organics.
Interestingly, compared with sham con-
trols, mice instilled with SootL and UfCP had 
Cyp1a1 expression that was about 3-fold down-
regulated; these are the two particle types with 
the highest innate OxPot, and the very same 
particles caused the strongest expression of the 
proinflammatory mediators (Cxcl1, Cxcl5, and 
Il6), which are regulated by redox-sensitive 
transcription factors. Hence, the transcriptional 
repression of Cyp1a1 might be explained by 
Figure 4. Immunohistologic staining of CYP1A1 protein expression in lungs 24 hr after 20 µg particle instillation showed broad positive staining in epithelial cells 
(red) and some alveolar macrophages (data not shown) of SootH-exposed mice. No staining was detected in sham- or SootL-exposed lungs. Agglomerates from 
SootH and SootL particles are clearly visible in the lungs. The arrow indicates a SootH-loaded macrophage containing agglomerated particles.
20 µm 20 µm 20 µm
Sham SootL SootHOrigin of particle-related oxidative stress
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inhibition of Cyp1a1 RNA expression by oxi-
dative stress in general. This interpretation is 
consistent with the autoregulatory mechanism 
described by Morel et al. (1999) in a human 
hepatoma cell line; they found that intracellular 
ROS production disturbs the AHR-dependent 
induction of Cyp1a1 expression, which rep-
resents a protective negative feedback loop. 
Alternatively, Gharavi and El-Kadi (2005) 
showed in murine hepatoma cell lines that 
Cyp1a1 is down-regulated by the proinflamma-
tory cytokines interleukin 1β (Il-1β), IL-6, and 
tumor necrosis factor α in an AHR-dependent 
manner. Even though both models address 
the liver and not the lung as studied here, this 
autoregulatory, ROS-protective mechanism 
could explain our observation that CDNPs 
with high innate OxPot induce significant 
down-regulation of Cyp1a1 expression.
Cyp1a1 and Cyp1b1, two closely related and 
essential extrahepatic phase I P450 monooxy-
genases, are highly inducible in the human 
lung by certain aromatic compounds, such as 
benzo(a)pyrene, via AHR signaling (reviewed 
by Martignoni et al. 2006). However, with our 
instillation approach we observed no depen-
dence of Cyp1b1 mRNA expression on organic 
compounds, because expression levels relative 
to controls were weakly induced by SootH to 
an expression level that is identical to that of 
SootL (1.4-fold). This apparent contradiction 
to the high expression of Cyp1a1 by SootH can 
be resolved if one considers that despite their 
close functional relationship, the CYP1A1 and 
CYP1B1 isoforms are regulated in a differ-
ent manner. For example, Cyp1a1 transcript 
expression is repressed by pro  inflammatory 
cytokines (Gharavi and El-Kadi 2005), whereas 
Cyp1b1 expression is induced (Piscaglia et al. 
1999). In this context, cAMP response ele-
ments as well as AP-1 sites—both frequently 
involved in proinflammatory signaling—have 
been identified in the murine Cyp1b1 but not 
Cyp1a1 promoter (Zheng and Jefcoate 2005).
In summary, our results support the fol-
lowing mechanistic scheme (Figure 5) for 
particle-related inflammation: On the one 
hand, particles with high innate OxPot (linked 
to low OC) generate direct oxidative stress 
by particle–cell interaction, which in turn 
activates redox-sensitive transcription of 
proinflammatory genes (pathway 1). On the 
other hand, particles with high amounts of 
bioavailable OC, such as PAHs, first induce 
phase I detoxification enzymes—in particu-
lar, CYP1A1 in exposed cells (pathway 2). 
Increased activity of CYP1A1 monooxyge-
nase in turn leads to biotransformation and 
bioactivation of PAHs with associated ROS 
formation. Consequently, the induced oxi-
dative stress activates transcription of both 
proinflammatory and phase II detoxification 
genes. The latter facilitate metabolization and 
conjugation of the highly active transformed 
organic compounds, ultimately leading to 
their elimination from the organism (Köhle 
and Bock 2007).
Quantitative model for IEf. The analysis 
presented here can be used to derive a simple, 
quantitative model for predicting the in vivo 
toxicity of CDNPs based on a simple in vitro 
assay for OxPot and (in vivo) Cyp1a1 gene or 
protein expression. As a first approach, we per-
formed a linear regression (forced through the 
origin) with the ascorbate-based in vitro test 
(OxPot) as independent and IEf as dependent 
parameters to obtain
 I Ef = 5.14OxPot (nmol/µg).  [1]
As a second approach, we modeled the 
in vivo IEf as linear function of both OxPot 
and Cyp1a1 gene expression (GECyp1a1 
expressed as fold induction after instillation 
of 20 µg particles), yielding
 I Ef = 5.14OxPot (nmol/µg)  
    + 0.509(GECyp1a1 – 1),  [2]
where we set GECyp1a1 to unity (no contribu-
tion from pathway 2), if Cyp1a1 was down-
regulated (< 1-fold). As shown in Figure 6A, 
the one-parameter model (pathway 1 only; 
Equation explains only 77% of the observed 
variability in IEf, whereas the two-parameter 
model, which considers contributions from 
pathways 1 and 2 (Equation 2), explains 
94%. This indicates that both pathways con-
tribute to the observed IEf. Because the small 
data set (six data points) required limiting the 
number of independent fit parameters, we 
reduced the number of fit parameters to two 
Figure 5. Mechanistic model for particle-related proinflammatory response that is consistent with our 
in vivo and in vitro data for CDNPs. The inflammatory signaling cascade is activated by oxidative stress 
due to the combined effects of the particles’ innate surface reactivity (measured as OxPot; pathway 1) and 
the presence of bioavailable organic compounds (Cyp1a1 induction; pathway 2), which are eliminated via 
a three-phase detoxification process. Abbreviations: H, high; L, low; PM, particulate matter. 
Pathway 1 Pathway 2
Driven by surface reactivity Organic compounds
OC-L
PM
OC-H
PM
Surface reactivity Phase I
(Cyp1a1   )
R
O
S
R
O
S
Oxidative effect
ROS
Proinflammatory response
NF-κBA P-1
Bioactivation
Biotransformation
Phase II
(Gst, Nqo1...   )
Nrf2
Phase III
Conjugation Elimination
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by assuming linearity (through the origin) 
and independence of pathways 1 and 2 (see 
Equation 2). Although this is likely to be only 
a crude approximation for complex biological 
systems, the agreement between measured 
and modeled IEf is remarkable. 
Because we derived our expression 
data from in vivo experiments, this model 
for toxicity prediction still requires animal 
exposures, although at a reduced amount. 
However, if future research will provide a 
means of obtaining Cyp1a1 expression data 
from the exposure of cell lines, the nanotoxi-
cologic model we present here may provide a 
true alternative to animal exposures.
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